GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » Other Operating Expense

Godavari Drugs (BOM:530317) Other Operating Expense : ₹220 Mil (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs Other Operating Expense?

Godavari Drugs's Other Operating Expense for the three months ended in Dec. 2023 was ₹58 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹220 Mil.

Godavari Drugs's quarterly Other Operating Expense increased from Jun. 2023 (₹56 Mil) to Sep. 2023 (₹62 Mil) but then declined from Sep. 2023 (₹62 Mil) to Dec. 2023 (₹58 Mil).

Godavari Drugs's annual Other Operating Expense increased from Mar. 2021 (₹167 Mil) to Mar. 2022 (₹200 Mil) and increased from Mar. 2022 (₹200 Mil) to Mar. 2023 (₹210 Mil).


Godavari Drugs Other Operating Expense Historical Data

The historical data trend for Godavari Drugs's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs Other Operating Expense Chart

Godavari Drugs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 136.79 134.59 167.05 199.60 210.28

Godavari Drugs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.99 44.27 55.77 62.17 57.61

Godavari Drugs Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹220 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Godavari Drugs Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Godavari Drugs (BOM:530317) Business Description

Traded in Other Exchanges
N/A
Address
Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003
Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines